| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000250303.2 |
Ponatinib |
Thyroid carcinoma |
0.044435748 |
Resistant |
| ENSG00000250303.2 |
Ponatinib |
Breast invasive carcinoma |
0.04318322 |
Sensitive |
| ENSG00000250303.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.004418902 |
Resistant |
